Postoperative Therapy After Interposition Arthroplasty in CMC1
1 other identifier
interventional
70
1 country
1
Brief Summary
In this randomized controlled trial the investigators want to investigate whether early versus late mobilisation after surgery in the first carpometacarpal joint (CMC1) leads to a faster recovery of hand function. The investigators also want to explore patients' satisfaction with the two different treatment regimes. The participants in the control group will receive the standard treatment at Diakonhjemmet hospital: immobilisation of the thumb in a splint for six weeks. The participants in the intervention group will use a soft splint for six weeks, but will be instructed to remove the splint daily to perform exercises for the thumb. A total of 70 patients will be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 23, 2012
CompletedFirst Posted
Study publicly available on registry
September 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMay 5, 2015
May 1, 2015
3.5 years
August 23, 2012
May 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in The Canadian Occupational Performance Measure (COPM) at 3, 6 and 12 months.
The COPM-assessment starts with an interview, addressing patient specific Hand Osteoarthritis (HOA)-related activity limitations within the areas self-care, productivity and leisure. The patient will thereafter rate the five most important activities for performance and satisfaction with performance, on 1 to 10-point scales (higher scores reflect better performance or higher satisfaction). The Norwegian version of the COPM has been tested for validity, reliability and responsiveness and has demonstrated good ability to detect functional changes in HOA.
Baseline, 3, 6 and 12 months
Change from baseline in Patient satisfaction with the rehabilitation regimen at 3, 6 and 12 months.
Each patient will be asked to complete a Numeric Rating Scale in order to give an opinion about their postoperative treatment regimen (splint-use, hand function, pain in the thumb, thumb movement and satisfaction with the operation).
Baseline, 3, 6 and 12 months
Secondary Outcomes (4)
Measure for activity performance (MAP-hand).
Baseline, 3, 6 and 12 months
Grip force and pinch grip
Baseline, 3, 6 and 12 months
Joint mobility
Baseline, 3, 6 and 12 months
Pain
Baseline, 3, 6, and 12 months
Other Outcomes (1)
Training diary
Intervention group: 2-6 weeks and 3-4 months. Control group: 6-10 weeks and 3-4 months.
Study Arms (2)
Early mobilisation after CMC1-surgery
ACTIVE COMPARATORMobilisation at two weeks after operation. The participants will wear a soft splint for six weeks.
Conservative treatment after CMC1-surgery
OTHERCurrent standard procedure: Mobilisation at six weeks after operation. The participants will wear a rigid splint for six weeks.
Interventions
Comparison of early (two weeks) and conservative (six weeks) mobilisation after operation. Comparison of rigid and soft thumb splint.
Eligibility Criteria
You may qualify if:
- Osteoarthritis in CMC1 diagnosed by radiography and a surgeon.
- Planned surgery(interposition arthroplasty) in CMC1
- Ability to communicate in Norwegian
You may not qualify if:
- Surgery involving other joints of the hand in addition to CMC1.
- Previous surgery of the same thumb.
- Other diseases og injuries that could influence hand function.
- Mental or cognitive deficit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diakonhjemmet hospital
Oslo, N-0370, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ingvild Kjeken, Ph.d
Department of Rheumatology, Diakonhjemmet hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Occupational therapist MSc
Study Record Dates
First Submitted
August 23, 2012
First Posted
September 6, 2012
Study Start
June 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2016
Last Updated
May 5, 2015
Record last verified: 2015-05